IPC Kidney: Principles of Drug Dosing in Kidney Diseases (Week 3)

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/114

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

115 Terms

1
New cards

which measure of eGFR is preferred? which is traditionally used for drug dosing?

CKDEPI 2021, cockroft-gault

2
New cards

which 2 measurements of eGFR have 20-30% discordance in dosing recommendations?

CKDEPI 2021 and cockcroft-gault

3
New cards

what are the criteria a drug has to meet to have NO CHANGE in regimen for kidney dysfunction pts?

large therapeutic index, fraction excreted unchanged in urine <=30%, metabolites are inactive (or no metabolites)

4
New cards

which PK factors can be changed?

ADME

5
New cards

for PK, what changes are seen in absorption?

largely unchanged

6
New cards

for PK, what changes are seen in distribution?

can be increased, decreased, or unchanged depending on the drug. consider protein and tissue binding changes/

7
New cards

for PK, what changes are seen in metabolism?

decrease in phase I enzyme capacity (CYP450 system), no change in phase II

8
New cards

phase II metabolites are eliminated by ___

kidney

9
New cards

for PK, what changes are seen in elimination?

decreased kidney elimination

10
New cards

what 2 pharmacodynamic changes can be seen?

increase in BBB permeability which increases CNS effects, decreased platelet aggregation which increases bleeding risk

11
New cards

___ inhibit CYP enzymes and drug transporters in the gut and liver, leading to...

uremic toxins, increased bioavailability and systemic exposure

12
New cards

what are the 2 big changes to hepatic metabolism?

altered 1st pass effect, metabolic processes altered (decreased phase I)

13
New cards

how does altered first pass effect impact hepatic metabolism?

decreased metabolism due to inactive metabolite leads to increased amount of active drug, leading to increased bioavailabilty

14
New cards

changes in PK during hepatic metabolism have a lot of pt variability, therefore...

not useful to predict clinical changes in dosing regimen

15
New cards

when morphine metabolites are not being eliminated by the kidney, what happens?

increased respiratory depression and CNS toxicity

16
New cards

which drugs can have metabolite accumulation?

allopurinol, cefotaxime, meperidine, morphine, primidone, sodium nitroprusside

17
New cards

which drug has a metabolite that has similar pharmacologic effect as the parent drug?

allopurinol

18
New cards

which drug has an inactive metabolite?

cefotaxime

19
New cards

which drugs have neurotoxic metabolites?

meperidine, morphine

20
New cards

which drug has a metabolite that is active drug?

primidone

21
New cards

which drug has a metabolite that causes cellular toxicity?

sodium nitroprusside

22
New cards

the ___ of the metabolite determines the clinical use of drug

effect

23
New cards

for drugs with metabolite accumulation, AVOID...

drugs with toxic metabolites

24
New cards

for drugs with metabolite accumulation, USE CAUTION...

with drugs that have pharmacologically active metabolites

25
New cards

for drugs with metabolite accumulation, MONITOR...

drugs with inactive metabolites

26
New cards

for opioid PK changes, the dose relates to ___

peak concentration which provides maximum pain relief

27
New cards

for opioid PK changes, the interval relates to ___

duration of pain relief

28
New cards

what are some changes in PD seen with opioids?

kidney dysfuntion increases sensitivity to therapeutic and toxic effects, increased opioid receptor sensitivity, increased BBB permeability increases CNS effects

29
New cards

clinical pearls for morphine dosing in kidney dysfunction

use caution in CKD, avoid in kidney failure (accumulation of active/toxic metabolite)

30
New cards

clinical pearls for codeine dosing in kidney dysfunction

case reports of narcosis, respiratory failure; avoid or use low doses in renal failure

31
New cards

clinical pearls for hydrocodone dosing in kidney dysfunction

reduce dose and/or extend interval; accumulation of active/toxic metabolite

32
New cards

clinical pearls for oxycodone dosing in kidney dysfunction

reduce dose and/or extend interval

33
New cards

clinical pearls for hydromorphone dosing in kidney dysfunction

drug of choice, 25% reduction in starting dose

34
New cards

clinical pearls for fentanyl dosing in kidney dysfunction

drug of choice, 25-50% reduction in starting dose

35
New cards

clinical pearls for methadone dosing in kidney dysfunction

reduce starting dose 50%

36
New cards

clinical pearls for meperidine dosing in kidney dysfunction

avoid, accumulation of neurotoxic metabolite

37
New cards

which opioids can you give in pts with kidney dysfunction?

fentanyl, methadone

38
New cards

which opioids can be given with caution in pts with kidney dysfunction?

hydromorphone, oxycodone, hydrocodone

39
New cards

which opioids need to be avoided in pts with kidney dysfunction?

morphine, codeine, meperidine

40
New cards

what changes in PK does renal dysfunction cause?

decrease GFR, decrease protein binding and increased fraction unbound, alteration in reabsorption and secretion processes

41
New cards

in SKI, ___ based assessments are inaccurate

SCr

42
New cards

in AKI dosing is based on...

diagnosis, pt condition and age, relative decline in kidney function, degree to which drug/metabolite eliminated by kidneys

43
New cards

how can urine output help determine an estimate of GFR?

non-oliguric: GFR >30

oliguric: GFR ~15-30

anuric: GFR <10

44
New cards

loading dose =

change in Cp * Vd

45
New cards

___ most affects loading dose

Vd

46
New cards

in general, loading dose for kidney dysfunction =

LD for normal kidney function

47
New cards

what are the 2 drug exceptions that require different loading doses in kidney dysfunction?

digoxin LD decreased by 50% (Vd reduced in kidney failure), hydrophilic antibiotics may need higher LD in volume overload/AKI

48
New cards

what are examples of hydrophilic antibiotics that may need an increased LD in volume overload or AKI?

aminoglycosides, beta lactams, carbapenems, glycopeptides, linezolid, colistin

49
New cards

___ most affects maintenance dose

CL

50
New cards

maintenance dose =

Css desired *(CL x dosing interval) / F

51
New cards

you can estimate maintenance dose by altering...

interval or dose using proportions

52
New cards

what is the interval method for maintenance dose?

(normal crcl/patients crcl) * normal interval

53
New cards

what is the dose method for maintenance dose?

(patients crcl/normal crcl) * normal dose

54
New cards

what are the antimicrobial agents that do not require dose adjustment for kidney dysfunction?

azithromycin, ceftriaxone, clindamycin, doxycycline, linezolid, metronidazole, moxifloxacin

55
New cards

for antibiotics, dose adjustment depends on what factors?

site of infection/antimicrobial tissue penetration, severity of illness, stability of renal function

56
New cards

dose adjustments for antibiotics have a high risk of ___

efficacy failure

57
New cards

for antibiotics, ___ is usually the same or higher in CKD/AKI

volume of distribution

58
New cards

for antibiotics loading doses should not be...

decreased, some should be increased

59
New cards

consider ___ dosing for antibiotics in AKI

24-48h of aggressive

60
New cards

which anticoagulant is a vitamin K antagonist?

warfarin

61
New cards

which anticoagulants are factor Xa inhibitors?

rivaroxaban, apixaban, fondaparinux, edoxaban

62
New cards

which anticoagulants are direct thrombin inhibitors?

dabigatran, bivalirudin, argatroban, lepirudin, desirudin

63
New cards

which anticoagulants are low-molecular weight heparin?

tinzaparin, enoxaparin, dalteparin

64
New cards

what change in PK happens with anticoagulants?

reduced kidney elimination

65
New cards

what change in PD happens with anticoagulants?

increased bleeding risk

66
New cards

how do anticoagulants increase bleeding risk in kidney disease?

kidney disease > uremia > platelet dysfunction > bleeding

67
New cards

what is the % kidney clearance for eliquis?

27%

68
New cards

what is the % kidney clearance for xarelto?

33%

69
New cards

what is the % kidney clearance for savaysa?

50%

70
New cards

what is the % kidney clearance for pradaxa?

80%

71
New cards

which DOACs have the most and least kidney clearance?

most: pradaxa, least: eliquis

72
New cards

what is the % kidney clearance for fondaparinux?

77%

73
New cards

what is the % kidney clearance for enoxaparin?

40-50%

74
New cards

what is the % kidney clearance for desirudin?

40-50%

75
New cards

what is the % kidney clearance for dalteparin?

33%

76
New cards

what is the % kidney clearance for bivalirudin?

20%

77
New cards

what is the % kidney clearance for tinzaparin?

minimal

78
New cards

which parenteral anticoagulants have the most and least kidney clearance?

most: fondaparinux, least: tinzaparin

79
New cards

how does volume of distribution change in edematous state?

increased Vd

80
New cards

how does volume of distribution change with muscle wasting/volume depletion?

decreased Vd

81
New cards

volume of distribution affects drug ___

concentration

82
New cards

protein binding alters ___ of drug

free fraction

83
New cards

how does hypoalbuminia affect free fraction of drug?

decreases protein binding > increased free fraction of drug > toxicity

84
New cards

what are the changes in PK seen for distribution?

Vd affects drug concentration, protein binding affects free fraction of drug, altered tissue binding

85
New cards

altered protein binding due to decreased affinity leads to...

decreased albumin, structural changes, or endogenous inhibitors (uremic toxins)

86
New cards

digoxin Vd decreases with renal disease due to...

decreased myocardial tissue uptake

87
New cards

how do you dose adjust metformin for egfr >45?

no adjustment

88
New cards

how do you dose adjust metformin for egfr 30-45?

consider 50% dose reduction

89
New cards

how do you dose adjust metformin for egfr <30?

contraindicated

90
New cards

what is the risk associated with metformin?

lactic acidosis

91
New cards

which drug must be discontinued 48h prior to IV contrast media?

metformin

92
New cards

which sulfonylurea is preferred in renal dysfunction?

glipizide

93
New cards

which sulfonylurea is bad in renal dysfunction?

glyburide

94
New cards

what is the risk associated with sulfonylureas?

prolonged hypoglycemia with long duration agents

95
New cards

___ provide better control than sulfonylureas but are does BID-TID

meglitinides

96
New cards

what are the 3 DPP4 inhibitors?

sitagliptin, saxagliptin, linagliptin

97
New cards

what is the brand name of sitagliptan?

januvia

98
New cards

what is the brand name of saxagliptan?

onglyza

99
New cards

what is the brand name of linagliptan?

tradjenta

100
New cards

what is the dose for sitagliptin with CrCl 30-50 ml/min?

50 mg once daily